Bone metabolism in 53 children and adolescents with chronic inflammatory bowel disease;Knochenstoffwechsel bei 53 kindern und jugendlichen mit chronisch entzündlichen darmerkrankungen

Klinische Padiatrie

Volumn 216, Issue 2, 2004, Pages 62-66

  Scheer, K ^a   Kratzsch, J ^b   Deutscher, J ^a   Gelbrich, C ^c   Borte, C ^a   Kiess, W ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Klin Chem und Molec Diagnostik   (Germany)

^c Koordinierungszentrum F Klin S   (Germany)

Author keywords

Bone metabolism; Bone mineral density; Corticosteroids; Crohn's disease; Osteopathy; Ulcerative colitis

Indexed keywords

PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE DISEASE; BONE METABOLISM; BONE MINERAL; CHILD; CHRONIC DISEASE; CLINICAL FEATURE; COLITIS; COLITIS INDETERMINATA; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; GASTROENTEROLOGY; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PREVALENCE; SYMPTOM; ULCERATIVE COLITIS;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROHN DISEASE; DENSITOMETRY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OSTEOPOROSIS; PREDNISONE; REFERENCE VALUES; RISK FACTORS;

EID: 1842738079     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-823145     Document Type: Article

References (29)

1. Abitbol V, Mary JY, Roux C, Soule JC, Belaiche J, Dupas J-L, Gendre JP, Lerebours E, Chaussade S, and the Groupe d'études thérapeutique des affections inflammatoires digestives (GETAID).. Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther 2002; 16: 919-927
2. Abitbol V, Roux C, Chaussade S, Guillement S, Kolta S, Dougados M, Couturier D, Amor B. Metabolic bone assessment in patients with inflammatory bwoel disease. Gastroenterology 1995; 108: 417-422
3. Anil M, Demirakca S, Dötsch J, Kiess W. Hypokalzämische Tetanie bei "alternativer" Sojamilch-Ernährung in den ersten Lebensmonaten. Klin Pädiatr 1996; 208: 323-326
4. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997; 40: 228-233
5. Cowan FJ, Warner JT, Dunstan FDJ, Evans WD, Gregory JW, Jenkins HR. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 1997; 76: 325-329
6. Dinca M, Fries W, Luisetto G, Peccolo F, Botegga F, Leone L, Naccarato R, Martin A. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 1999; 94: 1292-1296
7. Dolan AL, Monitz C, Dasgupta FLi, Mackintosh C, Todd P, Corrivall V, Panayi GS. Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica. Arthritis Rheum 1997; 40: 2022-2029
8. Faulkner RA, Bailey DA, Drinkwater DT, Mc Kay HA, Arnold C, Wilkinson AA. Bone densitometry in Canadian children 8-17 years of age. Calcif Tissue Int 1996; 59: 344-351
9. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerativ colitis, at diagnosis. Gastroenterology 1994; 107: 1031-1039
10. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998; 114: 902-911
11. Habtezion A, Silverberg MS, Parkes R, Mikolainis S, Steinhart AH. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 2002; 8: 87-92G
12. Harms HK, Blomer R, Bertele-Harms R-M, Shmerlin DH, König M, Spaeth A. Study Group on Crohn's Disease in Children and Adolescents.. A paediatric Crohn's disease activity index (PCDAI). Is it useful? Acta Paediatr Suppl 1994; 395: 22-26
13. Herzog D, Bishop N, Glorieux F, Seidmann EG. Interpretation of bone mineral density values in pediatric Crohn's disease. Inflamm Bowel Dis 1998; 4: 261-267
14. Hyams JS, Wyzga N, Kreutzer DL, Justinidi CJ, Gronowicz GA. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatric Gastroenterol Nutr 1997; 24: 289-295
15. Issenmann RM. Bone mineral metabolism in pediatric inflammatory bowel disease. Inflamm Bowel Dis 1999; 5: 192-199
16. Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997; 40: 313-319
17. Kaiser H, Ringe JD. Cortison und Osteoporose. Stuttgart: Thieme, 1996: 4-49
18. Klaus J, Armbrecht G, Steinkamp M, Brückel J, Rieber A, Adler G, Reinshagen M, Felsenberg D, von Tirpitz C. High prevalence of osteoporosis vertebral fractures in patients with Crohn's disease. Gut 2002; 51: 654-658
19. Kruse K. Calcium-Phosphat-Stoffwechselstörung. In: Kruse K (Hrsg). Pädiatrische Endokrinologie. 2. neu barbeitete Auflage. Stuttgart: Thieme, 1999: 111-154
20. LeBoff S. Is prolonged use of corticosteroids safe in patients with Crohns disease. Inflamm Bowel Dis 1997; 3: 169-173
21. Lee J-I, Chang R. Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea. J Gastroenterol Hepatol 2000; 15: 512-518
22. Reid IR. Glucocorticoid-induced osteoporosis. Baillière's Clin Endocrinol Metab 2000; 14: 279-298
23. Robinson RJ, Iqbal SJ, Abrams K, Al-Azzawi F, Mayberry JF. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998; 12: 699-705
24. Semeao EJ, Jawad AJ, Stallings VA, Piccoli DA. Effect of site of disease and steroid exposure on bone mineral density (BMD) in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1997; 25: A35
25. Semeao EJ, Jawad AJ, Stallings VA, Piccoli DA. Effect of site of disease and steroid exposure on bone mineral density (BMD) in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1997; 25: A35
26. Seo M, Okada M, Maeda K, Oh K. Correlation between endoscopic severity and clinical activity index in ulcerativ colitis. Am J Gastroenterology 1998; 93: 2124-2129
27. Silvennoinen JA. Relationship between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med 1996; 239: 131-137
28. von Tirpitz C, Pischulti G, Klaus J, Rieber A, Brückel J, Böhm BO, Adler G, Reinshagen M. Pathologische Knochendichte bei chronisch entzündlichen Darmerkrankungen - Prävalenz und Risikofaktoren. Z Gastroenterol 1999; 37: 5-12
29. Warner JT, Evans WD, Webb DKH, Bell W, Gregory JW. Relativ osteopenia after treatment for acute lymphoblastic leukemia. Pediatr Res 1999; 45: 544-551